Frontlight ResearchEarly access
CompletedNo phase
Optimizing the Influenza Clinical Decision Support Tool
Key facts
- Who runs it
- NYU Langone Health
- Where
- New York, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 25,881 people enrolled
- Started
- 16 Jan 2018
- Ended
- 21 Nov 2023
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Current Version of the Influenza Alert
- Alternate Modifications of the Influenza Alert
- Record updated
- 1 April 2024
Who can take part
- Age
- 3 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- All NYU Langone Health inpatients eligible for the Influenza clinical decision support tool
Who cannot take part
- N/A
Where in United States
- New York University School of MedicineNew York, United States
About the trial
What the trial wants to find out
The proposed study aims to examine several iterations of the Influenza Best Practice Alert at NYU Langone Health. The goal is to increase ordering of the influenza vaccine through the alert.
The 2 groups in the trial
- Usual CareExisting treatment, for comparison
The current version of the alert will fire for this arm of the study.
Treatment: Current Version of the Influenza Alert
- Alert IterationExisting treatment, for comparison
A modified version of the alert will fire for this arm of the study.
Treatment: Alternate Modifications of the Influenza Alert
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Applying A/B Testing to Clinical Decision Support: Rapid Randomized Controlled Trials.Journal of medical Internet research, 2021
- Record updated
- 1 April 2024